Project Grant R00HL166790
Award Date
12/1/24
Completion Date
11/30/27
Dollars Obligated
$498K
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Indiana, USA
Similar Awards
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $792,498 to the Trustees of Indiana University, Indianapolis (IU Indianapolis) to conduct research on hematopoietic stem cells (HSCs) and their regulation under low oxygen tension (hypoxia). The primary goals are to: 1) understand how hypoxia activates the transcription factor TFE3 to facilitate HSC self-renewal, 2) determine...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) provides $1,123,357.00 to support research on the bone marrow microenvironment and its role in regulating blood cell production. The research, to be conducted by the Children's Hospital Medical Center in Cincinnati, Ohio, aims to define the spatial organization and specialized vascular microenvironments within the bone marrow that recruit and...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $146,876 to the Coriell Institute for Medical Research to develop new methods for expanding functional hematopoietic stem cells (HSCs) from cryopreserved umbilical cord blood (UCB) samples. The project aims to optimize an approach using PPAR-α agonists, which have been shown to significantly expand long-term functional UCB HSCs...
This Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) supports research to investigate the role of a novel long non-coding RNA, MCRL1, in regulating human cardiac and hematopoietic differentiation. The $596,401 award to the Trustees of Indiana University, doing business as Indiana University Indianapolis, aims to decipher the transcriptional and epigenetic mechanisms by which MCRL1 interacts with the β-catenin signaling...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $153,117 to support a 5-year research project focused on improving hematopoietic stem cell (HSPC) transplantation outcomes. The goal is to investigate mechanisms of HSPC-niche cell crosstalk, specifically how HSPC-derived extracellular vesicles promote remodeling of bone marrow endothelial cells and migration of HSPCs. The...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) provides $487,567 to Indiana University to conduct integrative genomic analysis and develop high-dimensional risk prediction models for congenital heart defects (CHDs). The research aims to identify genetic variants and biological pathways associated with CHDs, as well as build predictive models leveraging genetic, epigenetic,...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $290,881 Project Grant under CFDA 93.837 (Cardiovascular Diseases Research) to the Trustees of Indiana University, doing business as Indiana University Indianapolis. The grant, titled "Indiana Stimulating Access to Research in Residency (I-STARR)", aims to train resident-physicians from primary care residency programs in research methods focused on understanding and reducing health disparities in cardiovascular and...
This Project Grant, awarded by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), provides $1,165,276 to Indiana University Indianapolis to investigate a novel immunocytokine therapy for suppressing inhibitor formation in hemophilia patients. The key products and services to be delivered under this 2-year award include preclinical assessments of the F5111-IC immunocytokine in multiple small and large animal models of hemophilia...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under CFDA Program 93.837 Cardiovascular Diseases Research, provides $295,438 to the University of Florida to conduct research on using the factor Netrin-1 (NTN1) to support the expansion and function of human hematopoietic stem cells (HSCs). The goal is to develop an ex vivo HSC expansion platform that can accelerate hematopoietic recovery and reduce complications for patients undergoing hematopoietic stem cell...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) provides $1,398,734 to the University of California, Merced to conduct research on understanding the role of the blood vascular system and endothelial cells in early thymus regeneration after cytotoxic treatments. The project aims to utilize novel intravital imaging techniques to directly analyze the live thymus and characterize the impact...